title: HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
authors.affiliation: Chung-Shan Medical University and Chung-ShanMedical University Hospital.
authors.forename: Chih-Ping
authors.initials: CP
authors.lastname: Han
authors.forename: Jeng-Dong
authors.initials: JD
authors.lastname: Hsu
authors.forename: Chung-Chin
authors.initials: CC
authors.lastname: Yao
authors.forename: Ming-Yung
authors.initials: MY
authors.lastname: Lee
authors.forename: Alexandra
authors.initials: A
authors.lastname: Ruan
authors.forename: Yeu-Sheng
authors.initials: YS
authors.lastname: Tyan
authors.forename: Shun-Fa
authors.initials: SF
authors.lastname: Yang
authors.forename: Hung
authors.initials: H
authors.lastname: Chiang
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000235:genetics* / Q000628:therapy; D005260:Female; D005784:Gene Amplification; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000628:therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human